Literature DB >> 16443764

Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry.

Gail Musen1, In Kyoon Lyoo, Caitlin R Sparks, Katie Weinger, Jaeuk Hwang, Christopher M Ryan, David C Jimerson, John Hennen, Perry F Renshaw, Alan M Jacobson.   

Abstract

The effects of type 1 diabetes and key metabolic variables on brain structure are not well understood. Sensitive methods of assessing brain structure, such as voxel-based morphometry (VBM), have not previously been used to investigate central nervous system changes in a diabetic population. Using VBM, we compared type 1 diabetic patients aged 25-40 years with disease duration of 15-25 years and minimal diabetes complications with an age-matched, nondiabetic control group. We investigated whether lower than expected gray matter densities were present, and if so, whether they were associated with glycemic control and history of severe hypoglycemic events. In comparison with control subjects, diabetic patients showed lower density of gray matter in several brain regions. Moreover, in the patient group, higher HbA(1c) levels and severe hypoglycemic events were associated with lower density of gray matter in brain regions responsible for language processing and memory. Our study represents the first comprehensive study of gray matter density changes in type 1 diabetes and suggests that persistent hyperglycemia and acute severe hypoglycemia have an impact on brain structure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443764     DOI: 10.2337/diabetes.55.02.06.db05-0520

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  113 in total

1.  Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

Authors:  Julie M Silverstein; Daniel Musikantow; Erwin C Puente; Dorit Daphna-Iken; Adam J Bree; Simon J Fisher
Journal:  Neurosci Lett       Date:  2011-01-25       Impact factor: 3.046

2.  Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults.

Authors:  Elizabeth C Leritz; David H Salat; Victoria J Williams; David M Schnyer; James L Rudolph; Lewis Lipsitz; Bruce Fischl; Regina E McGlinchey; William P Milberg
Journal:  Neuroimage       Date:  2010-10-28       Impact factor: 6.556

3.  Longitudinal Evaluation of Cognitive Functioning in Young Children with Type 1 Diabetes over 18 Months.

Authors:  M Allison Cato; Nelly Mauras; Paul Mazaika; Craig Kollman; Peiyao Cheng; Tandy Aye; Jodie Ambrosino; Roy W Beck; Katrina J Ruedy; Allan L Reiss; Michael Tansey; Neil H White; Tamara Hershey
Journal:  J Int Neuropsychol Soc       Date:  2016-01-20       Impact factor: 2.892

4.  Frontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complications.

Authors:  Timothy M Hughes; Christopher M Ryan; Howard J Aizenstein; Karen Nunley; Peter J Gianaros; Rachel Miller; Tina Costacou; Elsa S Strotmeyer; Trevor J Orchard; Caterina Rosano
Journal:  J Diabetes Complications       Date:  2013-08-30       Impact factor: 2.852

Review 5.  Diabetes and brain damage: more (or less) than meets the eye?

Authors:  Christopher M Ryan
Journal:  Diabetologia       Date:  2006-10       Impact factor: 10.122

Review 6.  Diabetic retinopathy is a neurodegenerative disorder.

Authors:  Stephanie K Lynch; Michael D Abràmoff
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

Review 7.  Diabetes mellitus and cognitive impairments.

Authors:  Elham Saedi; Mohammad Reza Gheini; Firoozeh Faiz; Mohammad Ali Arami
Journal:  World J Diabetes       Date:  2016-09-15

8.  Prefrontal cortical deficits in type 1 diabetes mellitus: brain correlates of comorbid depression.

Authors:  In Kyoon Lyoo; Sujung Yoon; Alan M Jacobson; Jaeuk Hwang; Gail Musen; Jieun E Kim; Donald C Simonson; Sujin Bae; Nicolas Bolo; Dajung J Kim; Katie Weinger; Junghyun H Lee; Christopher M Ryan; Perry F Renshaw
Journal:  Arch Gen Psychiatry       Date:  2012-12

9.  Long-term effect of diabetes and its treatment on cognitive function.

Authors:  Alan M Jacobson; Gail Musen; Christopher M Ryan; Nancy Silvers; Patricia Cleary; Barbara Waberski; Amanda Burwood; Katie Weinger; Meg Bayless; William Dahms; Judith Harth
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

Review 10.  The As and Ds of stress: metabolic, morphological and behavioral consequences.

Authors:  Lawrence P Reagan; Claudia A Grillo; Gerado G Piroli
Journal:  Eur J Pharmacol       Date:  2008-02-26       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.